A class action against implant maker Exactech has been stayed in light of its US bankruptcy, but a carve out allows the firm that brought the case to continue settlement negotiations.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
A judge has approved a $56 million settlement in a class action alleging Monash IVF destroyed potentially viable embryos, including a $10.6 million payout for the firm that ran the case.
Johnson & Johnson has been hit with a class action for allegedly pushing ineffective cold and flu medications containing phenylephrine onto customers for decades.
A judge has given the green light to a $31.5 million settlement in a class action brought by junior doctors accusing the ACT government and North Canberra Hospital of failing to pay overtime.
The competition regulator plans to block a group of Catholic hospital operators from collectively boycotting large private health insurers in the event funding negotiations fail.
A court has approved a $26.5 million settlement in a shareholder class action against regenerative medicine company Mesoblast.
Indian drug maker Cipla has lost a challenge to the extension of Novo Nordisk’s patent for Victoza, with a judge rejecting an argument that extensions can be granted only for active ingredients.
A class action on behalf of 700 patients alleging Monash IVF destroyed potentially viable embryos has told a court the majority of late registrants should not share in the $56 million settlement.